Medicine and Dentistry
Purinergic P2X4 Receptor
100%
Adenosine Triphosphate
80%
Interferon
60%
Receptor Gene
60%
Upregulation
60%
Vascular Endothelial Cell
60%
Gene Expression
40%
Messenger RNA
40%
Nucleotide
40%
Calcium Ion
40%
Human Umbilical Vein Endothelial Cell
40%
STAT1 Protein
40%
Cells
20%
Phosphorylation
20%
Development
20%
Receptor
20%
Therapeutic Procedure
20%
Protein
20%
Vasculitis
20%
Membrane Current
20%
Cycloheximide
20%
Uridine Triphosphate
20%
Epigallocatechin Gallate
20%
N Benzyl 2 Cyano 3 (3,4 Dihydroxyphenyl)acrylamide
20%
Genetic Transcription
20%
1 [[6 (3 Methoxyestra 1,3,5(10) Trien 17beta Yl)amino]hexyl] 1h Pyrrole 2,5 Dione
20%
Phospholipase C Inhibitor
20%
Janus Kinase Inhibitor
20%
Neuroscience
Purinergic P2X4 Receptor
100%
Adenosine Triphosphate
80%
Receptor Gene
60%
Interferon
60%
Gene Expression
40%
Human Umbilical Vein Endothelial Cell
40%
STAT1
40%
Eicosanoid Receptor
20%
Protein
20%
Phosphorylation
20%
Membrane Current
20%
Genetic Transcription
20%
Phospholipase C
20%
Uridine Triphosphate
20%
Epigallocatechin Gallate
20%
Cycloheximide
20%
Janus Kinase Inhibitor
20%
Biochemistry, Genetics and Molecular Biology
Interferon
60%
Receptor Gene
60%
Upregulation
60%
Western Blot
60%
Gene Expression
40%
Messenger RNA
40%
mRNA Stability
40%
STAT1
40%
Reverse Transcription Polymerase Chain Reaction
40%
Development
20%
Phosphorylation
20%
Phospholipase C
20%
Membrane Current
20%
Genetic Transcription
20%
Cycloheximide
20%
Epigallocatechin Gallate
20%
Janus Kinase Inhibitor
20%